Older onset essential tremor: More rapid progression and more degenerative pathology

Movement Disorders

Volumn 24, Issue 11, 2009, Pages 1606-1612

  Louis, Elan D ^a,b,c,f   Faust, Phyllis L ^b   Vonsattel, Jean Paul G ^b   Honig, Lawrence S ^a,b   Henchcliffe, Claire ^d   Pahwa, Rajesh ^e   Lyons, Kelly E ^e   Rios, Eileen ^a   Erickson Davis, Cordelia ^a   Moskowitz, Carol B ^a,b   Lawton, Arlene ^a,b  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b Weill Medical College of Cornell University ^*  (United States)

^c University of Kansas Medical Center ^*  (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^f NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Cerebellum; Degeneration; Essential tremor; Pathology; Purkinje cell; Rate of progression; Torpedo

Indexed keywords

ADULT; AGED; ARTICLE; AUTOPSY; CELL DENSITY; CLINICAL DATA REPOSITORY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEGENERATIVE DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ESSENTIAL TREMOR; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; ONSET AGE; PRIORITY JOURNAL; PURKINJE CELL; QUANTITATIVE ANALYSIS; REFERENCE DATABASE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AXONS; BIOLOGICAL SPECIMEN BANKS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ESSENTIAL TREMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PURKINJE CELLS; YOUNG ADULT;

EID: 69949172834     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22570     Document Type: Article

References (35)

1. Louis ED, Ford B, Barnes LF. Clinical subtypes of essential tremor. Arch Neurol 2000;57:1194-1198.
2. Dogu O, Louis ED, Sevim S, Kaleagasi H, Aral M. Clinical characteristics of essential tremor in Mersin, Turkey - a population-based door-to-door study. J Neurol 2005;252:570-574.
3. Benito-Leon J, Louis ED. Clinical update: diagnosis and treatment of essential tremor. Lancet 2007;369:1152-1154.
4. Zesiewicz TA, Elble R, Louis ED, et al. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2005;64:2008-2020.
5. Louis ED. Etiology of essential tremor: should we be searching for environmental causes? Mov Disord 2001;16:822-829.
6. Deng H, Le W, Jankovic J. Genetics of essential tremor. Brain 2007;130 (Part 6):1456-1464.
7. Tolosa E. Movement disorders: advances on many fronts. Lancet Neurol 2007;6:7-8.
8. Louis ED, Vonsattel JP, Honig LS, Ross GW, Lyons KE, Pahwa R. Neuropathologic findings in essential tremor. Neurology 2006; 66:1756-1759.
9. Louis ED, Vonsattel JP. The emerging neuropathology of essential tremor. Mov Disord 2007;23:174-182.
10. Ross GW, Dickson D, Cerosimo M, Tsuboi Y, Katsuse O, Petrovitch H. Pathological investigation of essential tremor. Neurology 2004;62 (Suppl 5):A537-A538.
11. Louis ED, Faust PL, Vonsattel JP, et al. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 2007;130 (Part 12):3297-3307.
12. Ashenhurst EM. The nature of essential tremor. Can Med Assoc J 1973;109:876-878.
13. Critchley M. Observations of essential (heredofamilial) tremor. Brain 1949;72:113-139.
14. Putzke JD, Whaley NR, Baba Y, Wszolek ZK, Uitti RJ. Essential tremor: predictors of disease progression in a clinical cohort. J Neurol Neurosurg Psychiatry 2006;77:1235-1237.
15. Louis ED, Schonberger RB, Parides M, Ford B, Barnes LF. Testretest reliability of patient information on age of onset in essential tremor. Mov Disord 2000;15:738-741.
16. Louis ED, Ottman R, Ford B, et al. The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology 1997;16:124-133.
17. Louis ED, Zheng W, Jurewicz EC, et al. Elevation of blood beta-carboline alkaloids in essential tremor. Neurology 2002;59:1940-1944.
18. Louis ED, Ford B, Bismuth B. Reliability between two observers using a protocol for diagnosing essential tremor. Mov Disord 198;13:287-293.
19. Louis ED, Wendt KJ, Albert SM, Pullman SL, Yu Q, Andrews H. Validity of a performance-based test of function in essential tremor. Arch Neurol 1999;56:841-846.
20. Louis ED, Ford B, Lee H, Andrews H. Does a screening questionnaire for essential tremor agree with the physician's examination? Neurology 1998;50:1351-1357.
21. Louis ED, Borden S, Moskowitz CB. Essential tremor centralized brain repository: diagnostic validity and clinical characteristics of a highly selected group of essential tremor cases. Mov Disord 2005;20:1361-1365.
22. Axelrad JE, Louis ED, Honig LS, et al. Reduced purkinje cell number in essential tremor: a postmortem study. Arch Neurol 2008; 65:101-107.
23. Louis ED, Vonsattel JP, Honig LS, et al. Essential tremor associated with pathologic changes in the cerebellum. Arch Neurol 2006; 63:1189-1193.
24. Harasymiw JW, Bean P. Identification of heavy drinkers by using the early detection of alcohol consumption score. Alcohol Clin Exp Res 2001;25:228-235.
25. Louis ED, Honig LS, Vonsattel JP, Maraganore DM, Borden S, Moskowitz CB. Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study. Arch Neurol 2005;62: 1004-1007.
26. Braak H, Braak E. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 1997;18(4 Suppl): S85-S88.
27. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006;112:389-404.
28. Mirra SS. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiol Aging 1997;18(4 Suppl):S91-S94.
29. Lee CS, Schulzer M, Mak EK, et al. Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 1994;117 (Part 3):501-507.
30. Mitnitski AB, Graham JE, Mogilner AJ, Rockwood K. The rate of decline in function in Alzheimer's disease and other dementias. J Gerontol A Biol Sci Med Sci 1999;54:M65-M69.
31. Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology 2005;65:1436-1441.
32. Gasparoli E, Delibori D, Polesello G, et al. Clinical predictors in Parkinson's disease. Neurol Sci 2002;23 (Suppl 2):S77-S78.
33. Kempster PA, Williams DR, Selikhova M, Holton J, Revesz T, Lees AJ. Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain 2007;130 (Part 8): 2123-2128.
34. Klockgether T, Ludtke R, Kramer B, et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain 1998;121 (Part 4):589-600.
35. Norris F, Shepherd R, Denys E, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993;118:48-55.